Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

Go back to Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
(NASDAQ: VVOS) Delayed: 0.17 -0.03 (15%)
Previous Close $0.20    52 Week High
Open $0.16    52 Week Low
Day High $0.17    P/E N/A 
Day Low $0.16    EPS
Volume 10,658,597       

(NASDAQ: VVOS) Delayed: 0.17 -0.03 (15%)
Previous Close $0.20    52 Week High
Open $0.16    52 Week Low
Day High $0.17    P/E N/A 
Day Low $0.16    EPS
Volume 10,658,597